Dexametasona Kern Pharma

Medicinal product

(Invented) name

Dexametasona Kern Pharma

Active substance (s)

Deksametazono natrio fosfatas

Strength

4 mg/ml

Pharmaceutical form

injekcinis ar infuzinis tirpalas

Route (s) of administration

leisti į veną, leisti į raumenis, leisti į sąnarį

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

H02AB02, Dexamethasone

Marketing authorisation holder

UAB Limedika, Lietuva

Date of authorisation

2021-06-14

Date of renewal

Documents

1538-001-002_Dexametasona Kern Pharma 4mg-ml_inj_inf_tirp_PZPL_2021-06-14.docx

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

Procedure number

Marketing authorisation procedure

Lygiagretus importas

Qualitative and quantitative composition

Ampulėje (1 ml) yra	1 ml
Deksametazono natrio fosfatas	4 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
106694	92797	1092797	ampulė	1 ml N3	ASPĮ	Receptinis	LT/L/21/1538/001	Netiekiama	-	-	No	-	-	Download
106695	92798	1092798	ampulė	1 ml N100	ASPĮ	Receptinis	LT/L/21/1538/002	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2021-06-14	Registruotas